Service provision in the wake of a new funding model for community pharmacy.

Show simple item record

dc.contributor.author Smith, Alesha J
dc.contributor.author Scahill, Shane L
dc.contributor.author Harrison, Jeff
dc.contributor.author Carroll, Tilley
dc.contributor.author Medlicott, Natalie J
dc.coverage.spatial England
dc.date.accessioned 2023-08-03T00:43:47Z
dc.date.available 2023-08-03T00:43:47Z
dc.date.issued 2018-05
dc.identifier.citation (2018). BMC Health Services Research, 18(1), 307-.
dc.identifier.issn 1472-6963
dc.identifier.uri https://hdl.handle.net/2292/65287
dc.description.abstract BACKGROUND:Recently, New Zealand has taken a system wide approach providing the biggest reform to New Zealand community pharmacy for 70 years with the aim of providing more clinically orientated patient centred services through a new funding model. The aim of this study was to understand the types of services offered in New Zealand community pharmacies since introduction of the new funding model, what the barriers are to providing these services. METHOD:A survey of all community pharmacies were undertaken between August, 2014 and February, 2015. Basic descriptive statistics were completed and group comparisons were made using the chi squared test with significance set at p < 0.05. RESULTS:528 responses were received. Education and advice on prescription and non-prescription medicines were the two top listed services provided. There were no significant differences in service provision between rural and metro based pharmacies. Many pharmacies were considering introducing new patient centred services. Four of the top ten frequently provided services have no public funding attached. Costs and staff availability are the most common barriers to undertake services, more predominantly in patient centred services. CONCLUSION:This study was the first to provide an evaluation of service provision in response to a new funding model for New Zealand Community Pharmacies. A broad range of services are being undertaken in New Zealand community pharmacies including patient-centred services. A number of barriers to service provision were identified. This study provides a baseline for the current levels of service provision upon which future studies can compare to and evaluate any changes in service provision with differing funding models going forward.
dc.format.medium Electronic
dc.language eng
dc.publisher Springer Nature
dc.relation.ispartofseries BMC health services research
dc.rights Items in ResearchSpace are protected by copyright, with all rights reserved, unless otherwise indicated. Previously published items are made available in accordance with the copyright policy of the publisher.
dc.rights.uri https://researchspace.auckland.ac.nz/docs/uoa-docs/rights.htm
dc.rights.uri http://creativecommons.org/licenses/by/4.0/
dc.subject Humans
dc.subject Health Policy
dc.subject Pharmacists
dc.subject Pharmacies
dc.subject Health Services
dc.subject Community Pharmacy Services
dc.subject Health Services Research
dc.subject Patient-Centered Care
dc.subject New Zealand
dc.subject Patient Education as Topic
dc.subject Surveys and Questionnaires
dc.subject Community pharmacy
dc.subject New funding models
dc.subject Patient-centred services
dc.subject Policy change
dc.subject Service provision
dc.subject 4203 Health Services and Systems
dc.subject 42 Health Sciences
dc.subject Clinical Research
dc.subject 8.1 Organisation and delivery of services
dc.subject 8 Health and social care services research
dc.subject 3 Good Health and Well Being
dc.subject Science & Technology
dc.subject Life Sciences & Biomedicine
dc.subject Health Care Sciences & Services
dc.subject CHRONIC DISEASE MANAGEMENT
dc.subject HEALTH-CARE
dc.subject FACILITATORS
dc.subject EXPERIENCES
dc.subject MEDICATION
dc.subject BARRIERS
dc.subject POLICY
dc.subject 1117 Public Health and Health Services
dc.subject Health services & systems
dc.subject 0807 Library and Information Studies
dc.subject 1110 Nursing
dc.subject 4205 Nursing
dc.subject 4206 Public health
dc.title Service provision in the wake of a new funding model for community pharmacy.
dc.type Journal Article
dc.identifier.doi 10.1186/s12913-018-3120-z
pubs.issue 1
pubs.begin-page 307
pubs.volume 18
dc.date.updated 2023-07-28T22:23:37Z
dc.rights.holder Copyright: The authors en
dc.identifier.pmid 29716610 (pubmed)
pubs.author-url https://www.ncbi.nlm.nih.gov/pubmed/29716610
pubs.publication-status Published
dc.rights.accessrights http://purl.org/eprint/accessRights/OpenAccess en
pubs.subtype Research Support, Non-U.S. Gov't
pubs.subtype research-article
pubs.subtype Journal Article
pubs.elements-id 740071
pubs.org-id Medical and Health Sciences
pubs.org-id Pharmacy
dc.identifier.eissn 1472-6963
dc.identifier.pii 10.1186/s12913-018-3120-z
pubs.number 307
pubs.record-created-at-source-date 2023-07-29
pubs.online-publication-date 2018-05-02


Files in this item

Find Full text

This item appears in the following Collection(s)

Show simple item record

Share

Search ResearchSpace


Browse

Statistics